Theravance Biopharma, Inc.

TBPH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001583107

SEC filings (opens in a new tab)

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Theravance Biopharma, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of TBPH: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	113	123	+10
Shares	64.2M	64.1M	−159.8K (−0.2%)
Value	$582.0M	$649.8M	+$67.8M (+11.7%)

New holders (23)

Institutions that held Theravance Biopharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to TBPH in Q3 2022
Institution	Shares	Value	% of portfolio
Two Sigma Advisers, LP	696,600	$7.06M	0.02%
Two Sigma Investments, LP	652,870	$6.62M	0.02%
Millennium Management LLC	650,558	$6.60M	0.01%
Rubric Capital Management LP	356,100	$3.61M	0.18%
Oasis Management Co Ltd.	296,960	$3.01M	0.52%
Highbridge Capital Management LLC	225,000	$2.28M	0.03%
Renaissance Technologies LLC	152,177	$1.54M	0.00%
Candriam Luxembourg S.C.A.	102,828	$1.04M	0.01%
Cannon Global Investment Management, LLC	65,000	$659.0K	1.06%
Caption Management, LLC	60,000	$608.0K	0.11%
Yakira Capital Management, Inc.	59,100	$599.0K	0.09%
Jump Financial, LLC	58,000	$588.0K	0.02%
Sagefield Capital LP	51,600	$523.0K	0.17%
Centiva Capital, LP	41,300	$419.0K	0.03%
Boothbay Fund Management, LLC	35,477	$360.0K	0.01%
XTX Topco Ltd	20,410	$207.0K	0.05%
Commonwealth of Pennsylvania Public School Empls Retrmt Sys	16,437	$167.0K	0.00%
CSS LLC	15,000	$153.0K	0.01%
China Universal Asset Management Co., Ltd.	716	$7.00K	0.00%
Massmutual Trust Co FSB	184	$2.00K	0.00%
Parallel Advisors, LLC	215	$2.00K	0.00%
Nisa Investment Advisors, LLC	68	$1.00K	0.00%
Bell Investment Advisors, Inc	50	$1.00K	0.00%

Sold out (13)

Institutions that held Theravance Biopharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of TBPH in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
OrbiMed Advisors LLC	1,370,250	$12.4M
Voloridge Investment Management, LLC	252,845	$2.29M
First Pacific Advisors, LP	176,539	$1.60M
Gsa Capital Partners LLP	114,646	$1.04M
Point72 Asset Management, L.P.	105,900	$959.0K
Tudor Investment Corp Et Al	103,280	$936.0K
Walleye Capital LLC	82,758	$750.0K
Zazove Associates LLC	59,599	$540.0K
King Wealth	45,000	$408.0K
Walleye Trading LLC	14,475	$131.0K
State of Wyoming	4,275	$39.0K
Captrust Financial Advisors	91	$1.00K
Elequin Capital LP	7	$0